NILHANZA Trademark

Trademark Overview

On Friday, January 27, 2023, a trademark application was filed for NILHANZA with the United States Patent and Trademark Office. The USPTO has given the NILHANZA trademark a serial number of 97771180. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, August 29, 2024. This trademark is owned by Nanocopoeia, LLC. The NILHANZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, those for use in human oncology; Tyrosine kinase inhibitors for use in the treatment of cancer; Drugs in the nature of pharmaceutical preparations for use in treating chronic myelogenous leukemia
nilhanza

General Information

Serial Number97771180
Word MarkNILHANZA
Filing DateFriday, January 27, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, August 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, those for use in human oncology; Tyrosine kinase inhibitors for use in the treatment of cancer; Drugs in the nature of pharmaceutical preparations for use in treating chronic myelogenous leukemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNanocopoeia, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMinneapolis, MN 55439
Party NameNanocopoeia, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew Brighton, MN 55112

Trademark Events

Event DateEvent Description
Tuesday, January 31, 2023NEW APPLICATION ENTERED
Wednesday, February 15, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 2, 2023ASSIGNED TO EXAMINER
Monday, May 8, 2023NON-FINAL ACTION WRITTEN
Monday, May 8, 2023NON-FINAL ACTION E-MAILED
Monday, May 8, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 9, 2023NON-FINAL ACTION WRITTEN
Tuesday, May 9, 2023NON-FINAL ACTION E-MAILED
Tuesday, May 9, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 7, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, August 7, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, November 9, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 29, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 4, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 29, 2024SOU EXTENSION 1 GRANTED
Thursday, August 29, 2024SOU EXTENSION 1 FILED
Tuesday, March 4, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 4, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 4, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 4, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 4, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 4, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 4, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 4, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, March 4, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

nilhanza preparations pharmaceutical nature drugs treating chronic leukemia myelogenous cancer inhibitors